NEW YORK, June 28, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders, today announced that Chairman and Chief Executive Officer, Daniel Chain, Ph.D., will present and meet one-on-one with potential investors at the OneMedForum 2010 Emerging Company Finance Conference in New York, NY on Wednesday, June 30, 2010. Dr. Chain's presentation will begin at 3:40 p.m. Eastern Time.
